Anti–IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria: A case series
The Journal of Allergy and Clinical Immunology: In Practice · 2023
DOI: 10.1016/j.jaip.2023.05.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023. Verfasst von Hanna Bonnekoh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin…. Hauptthemen laut MEDLINE: Chronic Urticaria, Anti-Allergic Agents, Urticaria. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; Fraunhofer Institute for Transl…
Zitieren
APA
Bonnekoh, H., Kiefer, L., Buttgereit, T., Kolkhir, P., Lütke-Eversloh, M., Scheffel, J., Maurer, M., & Metz, M. (2023). Anti–IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria: A case series. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.05.019
Vancouver
Bonnekoh H, Kiefer L, Buttgereit T, Kolkhir P, Lütke-Eversloh M, Scheffel J, et al. Anti–IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria: A case series. The Journal of Allergy and Clinical Immunology: In Practice. 2023. doi:10.1016/j.jaip.2023.05.019
BibTeX
@article{Bonnekoh2023,
author = {Bonnekoh, Hanna and Kiefer, Lea and Buttgereit, Thomas and Kolkhir, Pavel and Lütke-Eversloh, Marie and Scheffel, Jörg and Maurer, Marcus and Metz, Martin},
title = {Anti–IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria: A case series},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2023},
doi = {10.1016/j.jaip.2023.05.019}
}
EUVIMED